Lymphedema and Axillary-Lateral Thoracic Vessel Juncture Irradiation: A Clinical Dilemma
Open Access
- 4 August 2025
- journal article
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (4) , 301-306
Abstract
Regional nodal irradiation (RNI) is one of the main causes of breast cancer-related lymphedema (BCRL). However, studies on the relationship between the radiation dose to the axillary-lateral thoracic vessel juncture (ALTJ) region and BCRL have reported conflicting results. Based on these findings, we aimed to evaluate the clinical relevance of the dose to the ALTJ region in our patient cohort. Patients diagnosed with breast cancer and who were treated at Koç University Hospital between 2016 and 2022 and received RNI were included. BCRL was defined as a difference in arm circumference between the ipsilateral and contralateral limb >2.5 cm at any single encounter or ≥2 cm on ≥2 visits. ALTJ was retrospectively contoured, and doses were recorded as equivalent dose (α/β = 3). Of the 129 patients (median age 49 years) who met the inclusion criteria, 12 (9.3%) had lymphedema. Two-thirds of the patients (66.7%) were stage II, and one-third (33.3%) were stage III. The median follow-up was 22 months. The median (range) ALTJ Dmean dose was 18.11 (1.87-50) Gy, the median ALTJ Dmax was 44.53 (12.8-71.1) Gy, and the median ALTJ V35 was 38% (1-100%). No significant association was determined between ALTJ parameters and BCRL. There is insufficient data to define ALTJ as an OAR for decreasing BCRL risk. It is not appropriate to define dose and target based on ALTJ. Prospective studies with larger patient populations are needed to clarify the relationship between ALTJ and lymphedema.Keywords
This publication has 20 references indexed in Scilit:
- Determining the Organ at Risk for Lymphedema After Regional Nodal Irradiation in Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Pathophysiology of aged lymphatic vesselsAging, 2019
- Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volumeRadiotherapy and Oncology, 2019
- Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysisBreast Cancer Research and Treatment, 2016
- Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?Journal of Surgical Oncology, 2016
- Systematic review of axillary reverse mapping in breast cancerBritish Journal of Surgery, 2016
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialThe Lancet Oncology, 2014
- New anatomical classification of the axilla with implications for sentinel node biopsyBritish Journal of Surgery, 2010
- Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissectionJournal of Surgical Oncology, 2010
- Morbidity of Sentinel Node Biopsy in Breast Cancer: The Relationship Between the Number of Excised Lymph Nodes and LymphedemaAnnals of Surgical Oncology, 2010